Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $22.07 Analyst target: $33.48 Upside: 51.70%
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China.
See the full interactive analysis & chart →Informational only — not investment advice.